nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CHRFAM7A—corpus luteum—ovarian cancer	0.124	0.239	CbGeAlD
Pentobarbital—CHRNA7—corpus luteum—ovarian cancer	0.1	0.193	CbGeAlD
Pentobarbital—CHRFAM7A—ovarian follicle—ovarian cancer	0.0969	0.187	CbGeAlD
Pentobarbital—CHRNA7—ovarian follicle—ovarian cancer	0.0783	0.151	CbGeAlD
Pentobarbital—Ataxia—Altretamine—ovarian cancer	0.019	0.0546	CcSEcCtD
Pentobarbital—GRIA2—embryo—ovarian cancer	0.0144	0.0277	CbGeAlD
Pentobarbital—Hypoxia—Vinorelbine—ovarian cancer	0.0119	0.0341	CcSEcCtD
Pentobarbital—Respiratory failure—Topotecan—ovarian cancer	0.00896	0.0258	CcSEcCtD
Pentobarbital—Hepatocellular injury—Melphalan—ovarian cancer	0.00862	0.0248	CcSEcCtD
Pentobarbital—Injection site reaction—Melphalan—ovarian cancer	0.00857	0.0246	CcSEcCtD
Pentobarbital—CHRFAM7A—female reproductive system—ovarian cancer	0.00794	0.0153	CbGeAlD
Pentobarbital—Respiratory failure—Vinorelbine—ovarian cancer	0.00767	0.022	CcSEcCtD
Pentobarbital—Injection site reaction—Vinorelbine—ovarian cancer	0.00749	0.0215	CcSEcCtD
Pentobarbital—CHRFAM7A—female gonad—ovarian cancer	0.00723	0.0139	CbGeAlD
Pentobarbital—CHRNA7—uterus—ovarian cancer	0.00714	0.0138	CbGeAlD
Pentobarbital—GRIA2—testis—ovarian cancer	0.00704	0.0136	CbGeAlD
Pentobarbital—Ataxia—Chlorambucil—ovarian cancer	0.00675	0.0194	CcSEcCtD
Pentobarbital—GABRA5—testis—ovarian cancer	0.0066	0.0127	CbGeAlD
Pentobarbital—Dizziness—Altretamine—ovarian cancer	0.00656	0.0189	CcSEcCtD
Pentobarbital—CHRNA7—female reproductive system—ovarian cancer	0.00642	0.0124	CbGeAlD
Pentobarbital—CHRFAM7A—testis—ovarian cancer	0.00641	0.0124	CbGeAlD
Pentobarbital—Vomiting—Altretamine—ovarian cancer	0.00631	0.0181	CcSEcCtD
Pentobarbital—GABRA3—testis—ovarian cancer	0.00614	0.0118	CbGeAlD
Pentobarbital—Nausea—Altretamine—ovarian cancer	0.0059	0.017	CcSEcCtD
Pentobarbital—CHRNA7—female gonad—ovarian cancer	0.00584	0.0113	CbGeAlD
Pentobarbital—CYP2A6—vagina—ovarian cancer	0.0058	0.0112	CbGeAlD
Pentobarbital—Body temperature increased—Carboplatin—ovarian cancer	0.00542	0.0156	CcSEcCtD
Pentobarbital—GABRB3—gonad—ovarian cancer	0.00533	0.0103	CbGeAlD
Pentobarbital—CHRNA7—testis—ovarian cancer	0.00518	0.00998	CbGeAlD
Pentobarbital—Respiratory failure—Paclitaxel—ovarian cancer	0.00516	0.0148	CcSEcCtD
Pentobarbital—GABRA2—vagina—ovarian cancer	0.00512	0.00988	CbGeAlD
Pentobarbital—Injection site reaction—Paclitaxel—ovarian cancer	0.00504	0.0145	CcSEcCtD
Pentobarbital—GABRB2—testis—ovarian cancer	0.005	0.00965	CbGeAlD
Pentobarbital—Hallucination—Chlorambucil—ovarian cancer	0.00494	0.0142	CcSEcCtD
Pentobarbital—GABRB3—female reproductive system—ovarian cancer	0.00476	0.00918	CbGeAlD
Pentobarbital—Respiratory failure—Docetaxel—ovarian cancer	0.00437	0.0126	CcSEcCtD
Pentobarbital—Hepatocellular injury—Docetaxel—ovarian cancer	0.00429	0.0123	CcSEcCtD
Pentobarbital—Injection site reaction—Docetaxel—ovarian cancer	0.00427	0.0123	CcSEcCtD
Pentobarbital—Agitation—Chlorambucil—ovarian cancer	0.00397	0.0114	CcSEcCtD
Pentobarbital—Angioedema—Chlorambucil—ovarian cancer	0.00395	0.0114	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.0039	0.0112	CcSEcCtD
Pentobarbital—GABRB3—testis—ovarian cancer	0.00384	0.00741	CbGeAlD
Pentobarbital—CYP2C19—vagina—ovarian cancer	0.00373	0.00719	CbGeAlD
Pentobarbital—Confusional state—Chlorambucil—ovarian cancer	0.00356	0.0102	CcSEcCtD
Pentobarbital—Angioedema—Topotecan—ovarian cancer	0.00352	0.0101	CcSEcCtD
Pentobarbital—Ataxia—Paclitaxel—ovarian cancer	0.00346	0.00994	CcSEcCtD
Pentobarbital—Liver injury—Epirubicin—ovarian cancer	0.00344	0.00989	CcSEcCtD
Pentobarbital—GABRA2—lymph node—ovarian cancer	0.00331	0.00639	CbGeAlD
Pentobarbital—Liver injury—Doxorubicin—ovarian cancer	0.00318	0.00915	CcSEcCtD
Pentobarbital—Angioedema—Vinorelbine—ovarian cancer	0.00301	0.00865	CcSEcCtD
Pentobarbital—Ataxia—Docetaxel—ovarian cancer	0.00293	0.00842	CcSEcCtD
Pentobarbital—Feeling abnormal—Chlorambucil—ovarian cancer	0.00291	0.00836	CcSEcCtD
Pentobarbital—Hepatocellular injury—Epirubicin—ovarian cancer	0.0029	0.00833	CcSEcCtD
Pentobarbital—Injection site reaction—Epirubicin—ovarian cancer	0.00288	0.00828	CcSEcCtD
Pentobarbital—Hypotension—Melphalan—ovarian cancer	0.00287	0.00826	CcSEcCtD
Pentobarbital—Body temperature increased—Chlorambucil—ovarian cancer	0.00279	0.00802	CcSEcCtD
Pentobarbital—Constipation—Topotecan—ovarian cancer	0.00269	0.00772	CcSEcCtD
Pentobarbital—Hepatocellular injury—Doxorubicin—ovarian cancer	0.00268	0.0077	CcSEcCtD
Pentobarbital—Injection site reaction—Doxorubicin—ovarian cancer	0.00266	0.00766	CcSEcCtD
Pentobarbital—Hypersensitivity—Chlorambucil—ovarian cancer	0.0026	0.00747	CcSEcCtD
Pentobarbital—Bradycardia—Paclitaxel—ovarian cancer	0.00259	0.00744	CcSEcCtD
Pentobarbital—Feeling abnormal—Topotecan—ovarian cancer	0.00259	0.00744	CcSEcCtD
Pentobarbital—Hypotension—Vinorelbine—ovarian cancer	0.00251	0.00722	CcSEcCtD
Pentobarbital—Body temperature increased—Topotecan—ovarian cancer	0.00248	0.00714	CcSEcCtD
Pentobarbital—CYP3A4—female reproductive system—ovarian cancer	0.00244	0.0047	CbGeAlD
Pentobarbital—Hypersensitivity—Topotecan—ovarian cancer	0.00231	0.00665	CcSEcCtD
Pentobarbital—Constipation—Vinorelbine—ovarian cancer	0.0023	0.0066	CcSEcCtD
Pentobarbital—Hypersensitivity—Melphalan—ovarian cancer	0.00227	0.00651	CcSEcCtD
Pentobarbital—Vomiting—Chlorambucil—ovarian cancer	0.00224	0.00645	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00223	0.0064	CcSEcCtD
Pentobarbital—Feeling abnormal—Vinorelbine—ovarian cancer	0.00221	0.00636	CcSEcCtD
Pentobarbital—Tension—Paclitaxel—ovarian cancer	0.00217	0.00625	CcSEcCtD
Pentobarbital—Nervousness—Paclitaxel—ovarian cancer	0.00215	0.00618	CcSEcCtD
Pentobarbital—Body temperature increased—Vinorelbine—ovarian cancer	0.00212	0.00611	CcSEcCtD
Pentobarbital—Nausea—Chlorambucil—ovarian cancer	0.0021	0.00602	CcSEcCtD
Pentobarbital—Dizziness—Topotecan—ovarian cancer	0.00208	0.00597	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00206	0.00593	CcSEcCtD
Pentobarbital—Agitation—Paclitaxel—ovarian cancer	0.00203	0.00585	CcSEcCtD
Pentobarbital—Angioedema—Paclitaxel—ovarian cancer	0.00202	0.00582	CcSEcCtD
Pentobarbital—Vomiting—Topotecan—ovarian cancer	0.002	0.00574	CcSEcCtD
Pentobarbital—Syncope—Paclitaxel—ovarian cancer	0.00199	0.00571	CcSEcCtD
Pentobarbital—Rash—Topotecan—ovarian cancer	0.00198	0.00569	CcSEcCtD
Pentobarbital—Hypersensitivity—Vinorelbine—ovarian cancer	0.00198	0.00569	CcSEcCtD
Pentobarbital—Dermatitis—Topotecan—ovarian cancer	0.00198	0.00569	CcSEcCtD
Pentobarbital—Ataxia—Epirubicin—ovarian cancer	0.00198	0.00568	CcSEcCtD
Pentobarbital—Headache—Topotecan—ovarian cancer	0.00197	0.00566	CcSEcCtD
Pentobarbital—Vomiting—Melphalan—ovarian cancer	0.00196	0.00562	CcSEcCtD
Pentobarbital—Loss of consciousness—Paclitaxel—ovarian cancer	0.00195	0.00559	CcSEcCtD
Pentobarbital—Rash—Melphalan—ovarian cancer	0.00194	0.00557	CcSEcCtD
Pentobarbital—Dermatitis—Melphalan—ovarian cancer	0.00194	0.00557	CcSEcCtD
Pentobarbital—Anxiety—Paclitaxel—ovarian cancer	0.00188	0.0054	CcSEcCtD
Pentobarbital—Nausea—Topotecan—ovarian cancer	0.00187	0.00536	CcSEcCtD
Pentobarbital—Ataxia—Doxorubicin—ovarian cancer	0.00183	0.00526	CcSEcCtD
Pentobarbital—Nausea—Melphalan—ovarian cancer	0.00183	0.00525	CcSEcCtD
Pentobarbital—Confusional state—Paclitaxel—ovarian cancer	0.00182	0.00524	CcSEcCtD
Pentobarbital—Shock—Paclitaxel—ovarian cancer	0.00178	0.00511	CcSEcCtD
Pentobarbital—Dizziness—Vinorelbine—ovarian cancer	0.00178	0.00511	CcSEcCtD
Pentobarbital—Vomiting—Vinorelbine—ovarian cancer	0.00171	0.00491	CcSEcCtD
Pentobarbital—Rash—Vinorelbine—ovarian cancer	0.00169	0.00487	CcSEcCtD
Pentobarbital—Dermatitis—Vinorelbine—ovarian cancer	0.00169	0.00487	CcSEcCtD
Pentobarbital—Hypotension—Paclitaxel—ovarian cancer	0.00169	0.00485	CcSEcCtD
Pentobarbital—Headache—Vinorelbine—ovarian cancer	0.00168	0.00484	CcSEcCtD
Pentobarbital—Syncope—Docetaxel—ovarian cancer	0.00168	0.00484	CcSEcCtD
Pentobarbital—Loss of consciousness—Docetaxel—ovarian cancer	0.00165	0.00474	CcSEcCtD
Pentobarbital—Somnolence—Paclitaxel—ovarian cancer	0.00161	0.00462	CcSEcCtD
Pentobarbital—Nausea—Vinorelbine—ovarian cancer	0.0016	0.00459	CcSEcCtD
Pentobarbital—Constipation—Paclitaxel—ovarian cancer	0.00155	0.00444	CcSEcCtD
Pentobarbital—Confusional state—Docetaxel—ovarian cancer	0.00154	0.00444	CcSEcCtD
Pentobarbital—Shock—Docetaxel—ovarian cancer	0.00151	0.00433	CcSEcCtD
Pentobarbital—Feeling abnormal—Paclitaxel—ovarian cancer	0.00149	0.00428	CcSEcCtD
Pentobarbital—Bradycardia—Epirubicin—ovarian cancer	0.00148	0.00426	CcSEcCtD
Pentobarbital—Hypotension—Docetaxel—ovarian cancer	0.00143	0.00411	CcSEcCtD
Pentobarbital—Body temperature increased—Paclitaxel—ovarian cancer	0.00143	0.00411	CcSEcCtD
Pentobarbital—Bradycardia—Doxorubicin—ovarian cancer	0.00137	0.00394	CcSEcCtD
Pentobarbital—Somnolence—Docetaxel—ovarian cancer	0.00136	0.00391	CcSEcCtD
Pentobarbital—Hypersensitivity—Paclitaxel—ovarian cancer	0.00133	0.00383	CcSEcCtD
Pentobarbital—Constipation—Docetaxel—ovarian cancer	0.00131	0.00377	CcSEcCtD
Pentobarbital—Feeling abnormal—Docetaxel—ovarian cancer	0.00126	0.00363	CcSEcCtD
Pentobarbital—Tension—Epirubicin—ovarian cancer	0.00124	0.00357	CcSEcCtD
Pentobarbital—Nervousness—Epirubicin—ovarian cancer	0.00123	0.00353	CcSEcCtD
Pentobarbital—Body temperature increased—Docetaxel—ovarian cancer	0.00121	0.00348	CcSEcCtD
Pentobarbital—Dizziness—Paclitaxel—ovarian cancer	0.00119	0.00344	CcSEcCtD
Pentobarbital—Agitation—Epirubicin—ovarian cancer	0.00116	0.00334	CcSEcCtD
Pentobarbital—Tension—Doxorubicin—ovarian cancer	0.00115	0.0033	CcSEcCtD
Pentobarbital—Vomiting—Paclitaxel—ovarian cancer	0.00115	0.0033	CcSEcCtD
Pentobarbital—Rash—Paclitaxel—ovarian cancer	0.00114	0.00328	CcSEcCtD
Pentobarbital—Dermatitis—Paclitaxel—ovarian cancer	0.00114	0.00327	CcSEcCtD
Pentobarbital—Nervousness—Doxorubicin—ovarian cancer	0.00114	0.00327	CcSEcCtD
Pentobarbital—Syncope—Epirubicin—ovarian cancer	0.00114	0.00326	CcSEcCtD
Pentobarbital—Headache—Paclitaxel—ovarian cancer	0.00113	0.00325	CcSEcCtD
Pentobarbital—Hypersensitivity—Docetaxel—ovarian cancer	0.00113	0.00324	CcSEcCtD
Pentobarbital—Loss of consciousness—Epirubicin—ovarian cancer	0.00111	0.0032	CcSEcCtD
Pentobarbital—Agitation—Doxorubicin—ovarian cancer	0.00108	0.00309	CcSEcCtD
Pentobarbital—Anxiety—Epirubicin—ovarian cancer	0.00107	0.00309	CcSEcCtD
Pentobarbital—Nausea—Paclitaxel—ovarian cancer	0.00107	0.00309	CcSEcCtD
Pentobarbital—Syncope—Doxorubicin—ovarian cancer	0.00105	0.00302	CcSEcCtD
Pentobarbital—Confusional state—Epirubicin—ovarian cancer	0.00104	0.00299	CcSEcCtD
Pentobarbital—Loss of consciousness—Doxorubicin—ovarian cancer	0.00103	0.00296	CcSEcCtD
Pentobarbital—Shock—Epirubicin—ovarian cancer	0.00102	0.00292	CcSEcCtD
Pentobarbital—Dizziness—Docetaxel—ovarian cancer	0.00101	0.00291	CcSEcCtD
Pentobarbital—Anxiety—Doxorubicin—ovarian cancer	0.000994	0.00286	CcSEcCtD
Pentobarbital—Vomiting—Docetaxel—ovarian cancer	0.000974	0.0028	CcSEcCtD
Pentobarbital—Rash—Docetaxel—ovarian cancer	0.000966	0.00278	CcSEcCtD
Pentobarbital—Hypotension—Epirubicin—ovarian cancer	0.000965	0.00278	CcSEcCtD
Pentobarbital—Dermatitis—Docetaxel—ovarian cancer	0.000965	0.00277	CcSEcCtD
Pentobarbital—Confusional state—Doxorubicin—ovarian cancer	0.000964	0.00277	CcSEcCtD
Pentobarbital—Headache—Docetaxel—ovarian cancer	0.00096	0.00276	CcSEcCtD
Pentobarbital—Shock—Doxorubicin—ovarian cancer	0.00094	0.0027	CcSEcCtD
Pentobarbital—Somnolence—Epirubicin—ovarian cancer	0.000918	0.00264	CcSEcCtD
Pentobarbital—Nausea—Docetaxel—ovarian cancer	0.00091	0.00262	CcSEcCtD
Pentobarbital—Hypotension—Doxorubicin—ovarian cancer	0.000893	0.00257	CcSEcCtD
Pentobarbital—Constipation—Epirubicin—ovarian cancer	0.000883	0.00254	CcSEcCtD
Pentobarbital—Feeling abnormal—Epirubicin—ovarian cancer	0.000851	0.00245	CcSEcCtD
Pentobarbital—Somnolence—Doxorubicin—ovarian cancer	0.00085	0.00244	CcSEcCtD
Pentobarbital—Constipation—Doxorubicin—ovarian cancer	0.000817	0.00235	CcSEcCtD
Pentobarbital—Body temperature increased—Epirubicin—ovarian cancer	0.000817	0.00235	CcSEcCtD
Pentobarbital—Feeling abnormal—Doxorubicin—ovarian cancer	0.000788	0.00226	CcSEcCtD
Pentobarbital—Hypersensitivity—Epirubicin—ovarian cancer	0.000761	0.00219	CcSEcCtD
Pentobarbital—Body temperature increased—Doxorubicin—ovarian cancer	0.000756	0.00217	CcSEcCtD
Pentobarbital—Hypersensitivity—Doxorubicin—ovarian cancer	0.000704	0.00202	CcSEcCtD
Pentobarbital—Dizziness—Epirubicin—ovarian cancer	0.000683	0.00196	CcSEcCtD
Pentobarbital—Vomiting—Epirubicin—ovarian cancer	0.000657	0.00189	CcSEcCtD
Pentobarbital—Rash—Epirubicin—ovarian cancer	0.000651	0.00187	CcSEcCtD
Pentobarbital—Dermatitis—Epirubicin—ovarian cancer	0.000651	0.00187	CcSEcCtD
Pentobarbital—Headache—Epirubicin—ovarian cancer	0.000647	0.00186	CcSEcCtD
Pentobarbital—Dizziness—Doxorubicin—ovarian cancer	0.000632	0.00182	CcSEcCtD
Pentobarbital—Nausea—Epirubicin—ovarian cancer	0.000614	0.00176	CcSEcCtD
Pentobarbital—Vomiting—Doxorubicin—ovarian cancer	0.000608	0.00175	CcSEcCtD
Pentobarbital—Rash—Doxorubicin—ovarian cancer	0.000603	0.00173	CcSEcCtD
Pentobarbital—Dermatitis—Doxorubicin—ovarian cancer	0.000602	0.00173	CcSEcCtD
Pentobarbital—Headache—Doxorubicin—ovarian cancer	0.000599	0.00172	CcSEcCtD
Pentobarbital—Nausea—Doxorubicin—ovarian cancer	0.000568	0.00163	CcSEcCtD
Pentobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ovarian cancer	0.000458	0.00344	CbGpPWpGaD
Pentobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000406	0.00305	CbGpPWpGaD
Pentobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000401	0.00301	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—APC—ovarian cancer	0.000388	0.00291	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000368	0.00276	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000363	0.00272	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—SLC5A5—ovarian cancer	0.000353	0.00265	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000353	0.00264	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000348	0.00261	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—SLC2A1—ovarian cancer	0.000341	0.00256	CbGpPWpGaD
Pentobarbital—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000333	0.0025	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000332	0.00249	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000329	0.00247	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000323	0.00242	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000319	0.00239	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000318	0.00239	CbGpPWpGaD
Pentobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000317	0.00238	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000317	0.00238	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000311	0.00234	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000309	0.00232	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000309	0.00232	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000305	0.00229	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000304	0.00228	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000304	0.00228	CbGpPWpGaD
Pentobarbital—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000302	0.00227	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000299	0.00224	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—MTOR—ovarian cancer	0.000297	0.00223	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000297	0.00222	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000294	0.00221	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000291	0.00218	CbGpPWpGaD
Pentobarbital—CYP2A6—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000288	0.00216	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—CYP1B1—ovarian cancer	0.000287	0.00215	CbGpPWpGaD
Pentobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000279	0.0021	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000279	0.00209	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000275	0.00206	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—CASP3—ovarian cancer	0.000273	0.00205	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—APC—ovarian cancer	0.000271	0.00204	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000265	0.00199	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—CTNNB1—ovarian cancer	0.000264	0.00198	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.00026	0.00195	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000259	0.00194	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000255	0.00191	CbGpPWpGaD
Pentobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000254	0.00191	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000252	0.00189	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000249	0.00187	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000245	0.00183	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000244	0.00183	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000241	0.00181	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00024	0.0018	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.00024	0.0018	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000236	0.00177	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000234	0.00176	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.00023	0.00173	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—STAT3—ovarian cancer	0.00023	0.00172	CbGpPWpGaD
Pentobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000224	0.00168	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—MAPK3—ovarian cancer	0.000219	0.00165	CbGpPWpGaD
Pentobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000214	0.0016	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000211	0.00158	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.00021	0.00158	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—MAPK1—ovarian cancer	0.000209	0.00157	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—MTOR—ovarian cancer	0.000208	0.00156	CbGpPWpGaD
Pentobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000207	0.00155	CbGpPWpGaD
Pentobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000204	0.00153	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000201	0.00151	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000198	0.00149	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—CASP3—ovarian cancer	0.000191	0.00143	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000191	0.00143	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000186	0.00139	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—CTNNB1—ovarian cancer	0.000184	0.00138	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000184	0.00138	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00018	0.00135	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000179	0.00134	CbGpPWpGaD
Pentobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000178	0.00133	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000177	0.00133	CbGpPWpGaD
Pentobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000175	0.00132	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NME2—ovarian cancer	0.000175	0.00131	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.000175	0.00131	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000173	0.00129	CbGpPWpGaD
Pentobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000171	0.00129	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000169	0.00126	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000168	0.00126	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—HRAS—ovarian cancer	0.000168	0.00126	CbGpPWpGaD
Pentobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000166	0.00125	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000163	0.00122	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000162	0.00122	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—MAPK1—ovarian cancer	0.000161	0.00121	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000161	0.00121	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—STAT3—ovarian cancer	0.000161	0.00121	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000161	0.0012	CbGpPWpGaD
Pentobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.00016	0.0012	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00016	0.0012	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000158	0.00118	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000157	0.00118	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000156	0.00117	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000156	0.00117	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000156	0.00117	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000155	0.00116	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000154	0.00116	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000154	0.00115	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—MAPK3—ovarian cancer	0.000154	0.00115	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000153	0.00115	CbGpPWpGaD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000153	0.00115	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000152	0.00114	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000151	0.00113	CbGpPWpGaD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.00015	0.00113	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000149	0.00112	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000148	0.00111	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000148	0.00111	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—AKT1—ovarian cancer	0.000148	0.00111	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000147	0.0011	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—MAPK1—ovarian cancer	0.000146	0.0011	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	0.000146	0.0011	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000146	0.0011	CbGpPWpGaD
Pentobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000143	0.00107	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000142	0.00106	CbGpPWpGaD
Pentobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000141	0.00106	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00014	0.00105	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000135	0.00101	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000134	0.00101	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000134	0.001	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000132	0.000989	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000131	0.00098	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00013	0.000973	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—HRAS—ovarian cancer	0.000129	0.000969	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000129	0.000967	CbGpPWpGaD
Pentobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000129	0.000966	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000128	0.000962	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000128	0.000961	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000125	0.000939	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000125	0.000938	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000124	0.000933	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—MAPK1—ovarian cancer	0.000123	0.000923	CbGpPWpGaD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000123	0.000922	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000122	0.000916	CbGpPWpGaD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000121	0.000906	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000121	0.000905	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00012	0.000901	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.00012	0.0009	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—MAPK1—ovarian cancer	0.000119	0.000895	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000119	0.000895	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000118	0.000884	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—HRAS—ovarian cancer	0.000118	0.000882	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	0.000117	0.00088	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000117	0.000879	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000117	0.000879	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000115	0.000863	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000113	0.000848	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYTB—ovarian cancer	0.000113	0.000846	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000112	0.000843	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.00011	0.000828	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000107	0.000804	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NME2—ovarian cancer	0.000107	0.0008	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000106	0.000794	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000105	0.000789	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000104	0.000778	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	0.000104	0.000777	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000103	0.000772	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000102	0.000768	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—MAPK1—ovarian cancer	0.000102	0.000768	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—MAPK1—ovarian cancer	0.000101	0.000758	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—HRAS—ovarian cancer	9.88e-05	0.000741	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—BRIP1—ovarian cancer	9.85e-05	0.000739	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPP1CC—ovarian cancer	9.85e-05	0.000739	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.68e-05	0.000726	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	9.64e-05	0.000723	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—HRAS—ovarian cancer	9.58e-05	0.000719	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.41e-05	0.000706	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—MAPK1—ovarian cancer	9.24e-05	0.000693	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.24e-05	0.000693	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.08e-05	0.000681	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	9.05e-05	0.000679	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	9.04e-05	0.000678	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.02e-05	0.000677	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—MAPK1—ovarian cancer	8.98e-05	0.000673	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.86e-05	0.000664	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—MAPK1—ovarian cancer	8.82e-05	0.000661	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—MAPK1—ovarian cancer	8.66e-05	0.00065	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—MAPK1—ovarian cancer	8.61e-05	0.000646	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—MAPK1—ovarian cancer	8.45e-05	0.000634	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—HRAS—ovarian cancer	8.22e-05	0.000616	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—HRAS—ovarian cancer	8.11e-05	0.000609	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.74e-05	0.000581	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—HRAS—ovarian cancer	7.42e-05	0.000557	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—MAPK1—ovarian cancer	7.39e-05	0.000554	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	7.38e-05	0.000553	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—HRAS—ovarian cancer	7.21e-05	0.000541	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—HRAS—ovarian cancer	7.08e-05	0.000531	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—HRAS—ovarian cancer	6.96e-05	0.000522	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—HRAS—ovarian cancer	6.91e-05	0.000518	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYTB—ovarian cancer	6.87e-05	0.000516	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—HRAS—ovarian cancer	6.79e-05	0.000509	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6.72e-05	0.000504	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—YAP1—ovarian cancer	6.61e-05	0.000496	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NME2—ovarian cancer	6.41e-05	0.000481	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—BRIP1—ovarian cancer	6.01e-05	0.000451	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPP1CC—ovarian cancer	6.01e-05	0.000451	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—HRAS—ovarian cancer	5.93e-05	0.000445	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—FASN—ovarian cancer	5.39e-05	0.000404	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC5A5—ovarian cancer	5.3e-05	0.000398	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC2A1—ovarian cancer	5.12e-05	0.000384	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP1B1—ovarian cancer	4.91e-05	0.000368	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.38e-05	0.000328	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	4.35e-05	0.000326	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYTB—ovarian cancer	4.13e-05	0.00031	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCB1—ovarian cancer	4.04e-05	0.000303	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—YAP1—ovarian cancer	4.03e-05	0.000302	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.99e-05	0.000299	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TYMS—ovarian cancer	3.97e-05	0.000298	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPP1CC—ovarian cancer	3.61e-05	0.000271	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—BRIP1—ovarian cancer	3.61e-05	0.000271	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.51e-05	0.000263	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—FASN—ovarian cancer	3.28e-05	0.000246	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC5A5—ovarian cancer	3.23e-05	0.000242	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CAV1—ovarian cancer	3.2e-05	0.00024	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC2A1—ovarian cancer	3.12e-05	0.000234	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.06e-05	0.000229	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP1B1—ovarian cancer	2.99e-05	0.000224	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CG—ovarian cancer	2.91e-05	0.000219	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	2.65e-05	0.000199	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.64e-05	0.000198	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CD—ovarian cancer	2.56e-05	0.000192	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCB1—ovarian cancer	2.46e-05	0.000185	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—YAP1—ovarian cancer	2.42e-05	0.000182	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TYMS—ovarian cancer	2.42e-05	0.000182	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CB—ovarian cancer	2.23e-05	0.000167	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—FASN—ovarian cancer	1.98e-05	0.000148	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CAV1—ovarian cancer	1.95e-05	0.000146	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.94e-05	0.000146	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTEN—ovarian cancer	1.93e-05	0.000145	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.88e-05	0.000141	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.86e-05	0.00014	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.8e-05	0.000135	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.78e-05	0.000133	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.6e-05	0.00012	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.56e-05	0.000117	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.48e-05	0.000111	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TYMS—ovarian cancer	1.46e-05	0.000109	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.36e-05	0.000102	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CA—ovarian cancer	1.36e-05	0.000102	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTEN—ovarian cancer	1.18e-05	8.82e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CAV1—ovarian cancer	1.17e-05	8.8e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AKT1—ovarian cancer	1.11e-05	8.34e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.07e-05	8.01e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CD—ovarian cancer	9.39e-06	7.04e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CA—ovarian cancer	8.3e-06	6.22e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CB—ovarian cancer	8.18e-06	6.14e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTEN—ovarian cancer	7.07e-06	5.3e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AKT1—ovarian cancer	6.78e-06	5.08e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CA—ovarian cancer	4.99e-06	3.74e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AKT1—ovarian cancer	4.08e-06	3.06e-05	CbGpPWpGaD
